Reuters logo
Connecticut opioid treatment provider settles U.S., state probe
September 7, 2017 / 10:50 PM / 2 months ago

Connecticut opioid treatment provider settles U.S., state probe

A Connecticut substance abuse clinic operator and its former chief executive have agreed to pay $627,000 to resolve a probe into whether the nonprofit falsely claimed it had a medical director to administer treatments related to opioid addiction.

The settlement with Hartford Dispensary, which operates various outpatient treatments programs through its nine clinics, and ex-CEO Paul McLaughlin was announced on Thursday by federal and state authorities in Connecticut.

To read the full story on Westlaw Practitioner Insights, click here: bit.ly/2wMLtxP

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below